Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease

Jung, Han Na; Jung, Chang Hee

doi:2023.47.2.198

Diabetes Metab J > Volume 47(2); 2023 > Article

Editorial

Diabetes & Metabolism Journal 2023;47(2):198-200.
DOI: https://doi.org/10.4093/dmj.2023.0038 Published online March 15, 2023.

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease

Han Na Jung^1,2, Chang Hee Jung^1,2

¹Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
²Asan Diabetes Center, Asan Medical Center, Seoul, Korea

Correspondence: Chang Hee Jung,
Email: chjung0204@gmail.com

TOOLS

PDF Links
Full text via DOI
CrossRef TDM
Cited

Cited

export Copy Format

Close
Share :

METRICS

0 Crossref
0 Scopus
72 View
1 Download

ORCID iDs

Chang Hee Jung
https://orcid.org/0000-0003-4043-2396

Related articles

Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study2023 March;47(2)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients2021 May;45(3)

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr